GeneDx Holdings Corp reports results for the quarter ended in December - Earnings Summary

GeneDx Holdings

14/03/2023 21:56

* GeneDx Holdings Corp  WGS.OQ  reported a quarterly
adjusted loss
of 25 cents​​ per share for the quarter ended in December. The
mean expectation of four analysts for the quarter was for a loss
of 16 cents per share.
    * Revenue rose 6.1% to $61.35 million from a year ago;
analysts
expected $70.95 million. 
    * GeneDx Holdings Corp's reported EPS for the quarter was a
loss
of 88 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * GeneDx Holdings Corp shares had risen by 38.0% this
quarter.
    * The company reported a quarterly loss of $308.76 million.
    * Wall Street's median 12-month price target for GeneDx
Holdings
Corp is $1.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 14 at 09:56 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.16          -0.25          Missed
 Sep. 30 2022      -0.21          -0.20          Beat
 Jun. 30 2022      -0.21          -0.25          Missed
 Mar. 31 2022      -0.31          -0.31          Met